Browsing: flags

Wellness Tips

Study flags need to monitor frailty risks with GLP

By 0

July 14 (Reuters) – Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study that underscores concerns about how best to monitor seniors as U.S. Medicare expands access to GLP-1 therapies